Stem Cell Market Research Reports & Industry Analysis
Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.
Stem Cell Industry Research & Market Reports
-
Primary Immunodeficiency Therapeutics
... by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Antibody Deficiency Disease Type, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$8.5 ... Read More
-
Cancer Stem Cells
... by 2030, growing at a CAGR of 8.3% over the analysis period 2023-2030. Stem Cell-based Cancer Therapy, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$1.3 ... Read More
-
GMP Cell Banking Services
... reach US$2.2 Billion by 2030, growing at a CAGR of 15.0% over the analysis period 2023-2030. Biopharmaceutical Companies End-Use, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and ... Read More
-
Humanized Mouse and Rat Model
... is expected to reach US$219.4 Million by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Oncology Application, one of the segments analyzed in the report, is expected to record a 8.1% ... Read More
-
Stem Cell Services
... by 2030, growing at a CAGR of 9.8% over the analysis period 2023-2030. The U.S. Market is Estimated at US$7.5 Billion While China is Forecast to Grow at 9.0% CAGR The Stem Cell Services market ... Read More
-
Stem Cell Assays
... by 2030, growing at a CAGR of 17.9% over the analysis period 2023-2030. Instruments Component, one of the segments analyzed in the report, is expected to record a 18.4% CAGR and reach US$6.1 Billion by ... Read More
-
Umbilical Cord Blood Banking
... 2030, growing at a CAGR of 10.1% over the analysis period 2023-2030. Public Cord Blood Banks, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$4.3 Billion ... Read More
-
Stem Cell Therapy for Multiple Sclerosis Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
... Sclerosis from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, ... Read More
-
Animal Stem Cell Therapy Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
... 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major players, price ... Read More
-
Cell Therapy Market Analysis and Forecast to 2033: By Cell Type (Stem, T-Cell Therapy, Dendritic, Natural Killer, Mesenchymal Stem Cell, Induced Pluripotent Stem Cell), Therapeutic Area (Oncology, Cardiovascular Disorders, Neurological Disorders, Musculoskeletal Disorders, Autoimmune Disorders, Dermatological Disorders, Others), Application (Regenerative Medicine, Tissue Engineering, Immunotherapy, Gene Therapy, Cell-Based Assays, Others), End-User (Hospitals & Clinics, Research Institutes, Biotechnology, Pharmaceutical Companies), Stage Of Development (Preclinical, Phase I, Phase II, Phase III, Commercialized), Technology (Viral Vector-Based, Non-Viral Vector-Based, Gene Editing Technologies), Mode Of Delivery (Intravenous, Intramuscular, Subcutaneous, Others), and Region
... Dermatological Disorders, Others), Application (Regenerative Medicine, Tissue Engineering, Immunotherapy, Gene Therapy, Cell-Based Assays, Others), End-User (Hospitals & Clinics, Research Institutes, Biotechnology, Pharmaceutical Companies), Stage Of Development (Preclinical, Phase I, Phase II, Phase III, Commercialized), Technology ... Read More
-
Global Cell Freezing Medium for Cell Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... size was valued at US$ 108 million in 2023 and is forecast to a readjusted size of USD 258 million by 2030 with a CAGR of 13.5% during review period. Cell Freezing Medium for Cell ... Read More
-
Global Stem Cell Therapy for Osteoarthritis Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... progressive to joint stiffness, swelling, pain, and loss of mobility. The prevalence rate of OA is extremely high, affecting more than 250 million people worldwide. With increases in the aging and obese populations, the prevalence ... Read More
-
Global Organoids And Spheroids Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Organoids And Spheroids is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global CAR T-Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because ... Read More
-
Global 3D Cell Culture Market 2024-2028
... cell culture market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Organoids Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity and Efficacy Testing, Drug Discovery and Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), Offering (Instruments, Consumables, and Services), Method (Micropatterned Plates, Ultralow Attachment Plates, Hanging Drop, Microdroplet/Emulsion, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... of Infectious Disease, Regenerative Medicine, Drug Toxicity and Efficacy Testing, Drug Discovery and Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), Offering (Instruments, Consumables, and Services), Method (Micropatterned Plates, ... Read More
-
C-X-C Chemokine Receptor 4 (CXCR4) Antagonists Global Market Report 2024 Including: 1) By Type: BL-8040; GMI-1359; Plerixafor (AMD3100); Balixafortide (POL6326); USL311; Burixafor (GPC-100) 2) By Route Of Administration: Oral; Injectable 3) By Product Pipeline: Approved; Clinical Trials; Pre-Clinical 4) By Application: Cancer; Human Immunodeficiency Virus (HIV); Chronic Inflammatory Disease; Stem Cell Mobilization; Immune And Autoimmune Diseases 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies Covering: Pfizer Inc.; F-Hoffmann La Roche Ltd.; Sanofi; Bristol-Myers Squibb Company; AstraZeneca plc
... Pre-Clinical4) By Application: Cancer; Human Immunodeficiency Virus (HIV); Chronic Inflammatory Disease; Stem Cell Mobilization; Immune And Autoimmune Diseases5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: Pfizer Inc.; F-Hoffmann La Roche Ltd.; Sanofi; Bristol-Myers ... Read More
-
Global Organoids Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... organ functionality. According to our (Global Info Research) latest study, the global Organoids market size was valued at US$ 109 million in 2023 and is forecast to a readjusted size of USD 341 million by ... Read More
-
Global Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate ... Read More
-
Global Natural Killer Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... one of the most promising breakthroughs in cancer treatment. NK cells are the body"s first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells. According to ... Read More
-
Global Cell Freezing Media for Cell Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... cell freezing media containing dimethyl sulfoxide (DMSO) as the active freezing agent. However, since it is known that DMSO is a mutagen and carcinogen, DMSO-free formulations are becoming popular for stem cell applications. This is ... Read More
-
Global Stem Cell Therapy Market: Analysis By Type, By Stem Cell Source, By Application, By End User, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... Metrics Details Years Considered 2019-2029 Base Year 2023 Forecast Period 2024-2029 Page Count 154 Units Referenced US $ Segments/Key Topics By Type, By Stem Cell Source, By Application, By End-user Regions Covered North America (The ... Read More
-
Global NK Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... of the most promising breakthroughs in cancer treatment. NK cells are the body"s first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells. According to our ... Read More
-
Adeno-Associated Virus (AAV) CDMO Market Size & Share Analysis - Growth, Trends & Forecasts (2024-2029)
... 1.40 billion by 2029, growing at a CAGR of 20.86% during the forecast period (2024-2029). The key factors driving the growth of the adeno-associated virus CDMO market include the increasing use of gene therapy, advancements ... Read More
-
Global Cell therapy Processing Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Cell therapy Processing is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
Research Assistance
